Literature DB >> 14614371

Endotoxemia and elevation of lipopolysaccharide-binding protein after hematopoietic stem cell transplantation.

Ofer Levy1, Armando Teixeira-Pinto, Mark L White, Stephen F Carroll, Leslie Lehmann, David Wypij, Eva Guinan.   

Abstract

BACKGROUND: Hematopoietic stem cell transplantation (SCT) carries a significant risk of severe therapy-associated complications chief among which is acute graft vs.host disease (aGVHD). Animal models indicate that myeloablative chemotherapy compromises the mucosal barrier, thereby allowing translocation of intestinal flora-derived lipopolysaccharides (or endotoxin) that subsequently trigger aGVHD, but there are no comparable data in humans. Our aim was to gain insight into the potential role of endotoxin and endotoxin-induced acute phase proteins in children undergoing SCT.
METHODS: Plasma concentrations of C-reactive protein (CRP) and lipopolysaccharide-binding protein (LBP) were measured in 57 pediatric patients undergoing SCT. In addition plasma endotoxin levels were measured in 25 patients.
RESULTS: The previously described rise in CRP was confirmed, and a marked elevation of LBP was observed that peaked at Day 7 (median value, 6.6 microg/ml; P < 0.03 for all pairwise comparisons). CRP and LBP values were significantly correlated (r = 0.77, P < 0.001). A significant but complex relationship was noted between LBP concentrations at Day 0 and severity of subsequent aGVHD (P = 0.02). Of the 25 patients assayed, 11 (44%) had detectable endotoxemia, including 4 who were endotoxin-positive at Day 0.
CONCLUSIONS: The detection of endotoxemia coupled with marked elevations in LBP at Day 7 raises the possibility that inflammatory responses early after SCT may be driven in part by the entry of lipopolysaccharide into the bloodstream.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14614371     DOI: 10.1097/01.inf.0000095196.19606.d2

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  7 in total

1.  17(R)-Resolvin D1 differentially regulates TLR4-mediated responses of primary human macrophages to purified LPS and live E. coli.

Authors:  Christine D Palmer; Christy J Mancuso; Jerrold P Weiss; Charles N Serhan; Eva C Guinan; Ofer Levy
Journal:  J Leukoc Biol       Date:  2011-06-07       Impact factor: 4.962

2.  Identification of single nucleotide polymorphisms in hematopoietic cell transplant patients affecting early recognition of, and response to, endotoxin.

Authors:  Eva C Guinan; Christine D Palmer; Christy J Mancuso; Lisa Brennan; Liat Stoler-Barak; Leslie A Kalish; Eugenie E Suter; Leighanne C Gallington; David P Huhtelin; Maria Mansilla; Ralf R Schumann; Jeffrey C Murray; Jerrold Weiss; Ofer Levy
Journal:  Innate Immun       Date:  2013-10-09       Impact factor: 2.680

3.  Plasma level of lipopolysaccharide-binding protein is indicative of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.

Authors:  Haige Ye; Meng Lv; Xiaosu Zhao; Xiangyu Zhao; Xiaojun Huang
Journal:  Int J Hematol       Date:  2012-05-03       Impact factor: 2.319

4.  Serum and Extracellular Vesicle MicroRNAs miR-423, miR-199, and miR-93* As Biomarkers for Acute Graft-versus-Host Disease.

Authors:  Rachel E Crossland; Jean Norden; Mateja Kralj Juric; Kim F Pearce; Clare Lendrem; Louis A Bibby; Matthew Collin; Hildegard T Greinix; Anne M Dickinson
Journal:  Front Immunol       Date:  2017-11-10       Impact factor: 7.561

5.  Acute binge drinking increases serum endotoxin and bacterial DNA levels in healthy individuals.

Authors:  Shashi Bala; Miguel Marcos; Arijeet Gattu; Donna Catalano; Gyongyi Szabo
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

6.  Pilot experience with opebacan/rBPI 21 in myeloablative hematopoietic cell transplantation.

Authors:  Eva Guinan; David E Avigan; Robert J Soiffer; Nancy J Bunin; Lisa L Brennan; Ilana Bergelson; Spencer Brightman; Al Ozonoff; Patrick J Scannon; Ofer Levy
Journal:  F1000Res       Date:  2015-12-21

Review 7.  Host impairments in patients with neoplastic diseases.

Authors:  J Peter Donnelly; Nicole M A Blijlevens; Walter J F M van der Velden
Journal:  Cancer Treat Res       Date:  2014
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.